ReportWire

Tag: Bats

  • Prime Capital Investment Advisors LLC Sells 884 Shares of iShares MSCI EAFE Growth ETF $EFG

    [ad_1]

    Prime Capital Investment Advisors LLC trimmed its holdings in shares of iShares MSCI EAFE Growth ETF (BATS:EFGFree Report) by 22.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,043 shares of the company’s stock after selling 884 shares during the period. Prime Capital Investment Advisors LLC’s holdings in iShares MSCI EAFE Growth ETF were worth $341,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

    Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Breakwater Investment Management bought a new position in iShares MSCI EAFE Growth ETF during the 1st quarter worth about $28,000. AlphaCore Capital LLC bought a new position in iShares MSCI EAFE Growth ETF during the 1st quarter worth about $29,000. GAMMA Investing LLC grew its holdings in iShares MSCI EAFE Growth ETF by 9,900.0% during the 1st quarter. GAMMA Investing LLC now owns 400 shares of the company’s stock worth $40,000 after acquiring an additional 396 shares in the last quarter. Woodside Wealth Management LLC bought a new position in iShares MSCI EAFE Growth ETF during the 1st quarter worth about $40,000. Finally, Christopher J. Hasenberg Inc bought a new position in iShares MSCI EAFE Growth ETF during the 1st quarter worth about $42,000.

    iShares MSCI EAFE Growth ETF Price Performance

    Shares of iShares MSCI EAFE Growth ETF stock opened at $112.90 on Friday. iShares MSCI EAFE Growth ETF has a 1 year low of $88.66 and a 1 year high of $113.16. The firm’s 50-day moving average is $112.52 and its two-hundred day moving average is $108.43. The stock has a market cap of $13.28 billion, a price-to-earnings ratio of 24.98 and a beta of 0.96.

    iShares MSCI EAFE Growth ETF Company Profile

    (Free Report)

    iShares MSCI EAFE Growth ETF (the Fund), formerly iShares MSCI EAFE Growth Index Fund, is an exchange-traded fund (ETF). The Fund seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI EAFE Growth Index (the Index). The Index is a subset of the MSCI EAFE Index and constituents of the Index include securities from Europe, Australasia (Australia and Asia), and the Far East.

    See Also

    Want to see what other hedge funds are holding EFG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares MSCI EAFE Growth ETF (BATS:EFGFree Report).

    Institutional Ownership by Quarter for iShares MSCI EAFE Growth ETF (BATS:EFG)



    Receive News & Ratings for iShares MSCI EAFE Growth ETF Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for iShares MSCI EAFE Growth ETF and related companies with MarketBeat.com’s FREE daily email newsletter.

    [ad_2]

    ABMN Staff

    Source link

  • Invesco AAA CLO Floating Rate Note ETF (ICLO) to Issue Dividend of $0.16 on  September 27th

    Invesco AAA CLO Floating Rate Note ETF (ICLO) to Issue Dividend of $0.16 on September 27th

    [ad_1]

    Invesco AAA CLO Floating Rate Note ETF (BATS:ICLOGet Free Report) declared a dividend on Friday, September 20th, NASDAQ reports. Shareholders of record on Monday, September 23rd will be given a dividend of 0.1614 per share on Friday, September 27th. The ex-dividend date is Monday, September 23rd. This is an increase from Invesco AAA CLO Floating Rate Note ETF’s previous dividend of $0.15.

    Invesco AAA CLO Floating Rate Note ETF Stock Performance

    ICLO stock traded up $0.02 during mid-day trading on Friday, reaching $25.77. 67,338 shares of the company traded hands. The company has a fifty day simple moving average of $25.68 and a 200 day simple moving average of $25.67.

    About Invesco AAA CLO Floating Rate Note ETF

    (Get Free Report)

    The Invesco Aaa Clo Floating Rate Note ETF (ICLO) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund is actively managed to invest in USD-denominated floating rate CLOs that are rated AAA or equivalent. ICLO was launched on Dec 9, 2022 and is managed by Invesco.

    Read More

    Dividend History for Invesco AAA CLO Floating Rate Note ETF (BATS:ICLO)

    Receive News & Ratings for Invesco AAA CLO Floating Rate Note ETF Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Invesco AAA CLO Floating Rate Note ETF and related companies with MarketBeat.com’s FREE daily email newsletter.

    [ad_2]

    ABMN Staff

    Source link

  • Bats Could Hold the Secret to Better, Longer Human Life

    Bats Could Hold the Secret to Better, Longer Human Life

    [ad_1]

    In Linfa Wang’s ideal world, all humans would be just a bit more bat-like.

    Wang, a biochemist and zoonotic-disease expert at Duke-NUS Medical School, in Singapore, has no illusions about people flapping about the skies or echolocating to find the best burger in town. The point is “not to live like a bat,” Wang told me, but to take inspiration from their very weird physiology in order to boost the quality, or even the length, of human life. They might not look it, but bats, Wang said, are “the healthiest mammals on Earth.”

    That thought might be tough to square with bats’ recent track record. In the past three decades—from 1994, when Hendra virus jumped to humans, to 2019, when SARS-CoV-2 emerged—at least half a dozen of the most devastating viral epidemics known to have recently leapt into people from wildlife have had their likeliest origins in bats. But bats themselves rarely, if ever, seem to fall ill. Ebola, Nipah, Marburg, and various coronaviruses don’t appear to trouble them; some bats can survive encounters with rabies, which, left untreated in humans, has a near 100 percent fatality rate. “They’ve evolved mechanisms to limit the damage of disease,” says Emma Teeling, a bat biologist at University College Dublin, who collaborates with Wang.

    The creatures’ apparent ability to defy death goes even beyond that. Some nectar-devouring species spend years spiking their blood-sugar levels high enough to send a human into a hyperglycemic coma—and yet, those bats never seem to develop what we’d call diabetes. Others have been documented surviving up to 41 years in the wild—nearly 10 times as long as mammals of their size are generally expected to live—all the while avoiding cancer and fertility dips.

    Wang and Teeling, along with several colleagues, were recently awarded a $13 million grant by the European Research Council to try to better understand the biology behind these batty abilities—and how it might help other creatures. (And they’re certainly not the only ones trying to find out.) Wang’s team, as he likes to cheerfully boast, has already put some of his ideas to the test by genetically engineering a healthier, more disease-tolerant “bat-mouse.” He and his colleagues are still years away from creating any sort of bat person, but they are confident that this line of thinking could one day inform new treatments for humans—to combat diabetes, to temper infectious diseases, maybe even to extend the life span.

    The key to bats’ health seems to be flight, or at least the effects that evolving flight has had on the bat body. Flight, for all its perks, is one of the most energetically taxing transportation options: When bats fly, their metabolism can rev up to 15 to 16 times above its resting state; their heart rate may soar above 1,000 beats per minute; their body temperature can exceed 105 degrees Fahrenheit, effectively plunging the animals into an epic fever state. Put all of that on virtually any other mammal, and their body would likely be overwhelmed by the blaze of extreme inflammation, the toxic by-products of their metabolism effectively rending cells apart.

    To cope with this self-destructive form of locomotion, bats have evolved two essential safeguards. First, they are extraordinarily good at maintaining bodily Zen. Even when pushed into extreme forms of exertion, bat bodies don’t get all that inflamed—maybe in part because they lack some of the molecular machinery that kicks those systems into gear. Which means that bats simply rack up less damage when their bodies get stressed. And for any damage that does occur, bats have a second trick: Their cells appear to be unusually efficient at cleanup and repair, rapidly stitching back together bits of torn-up DNA.

    Those strategies, Wang and Teeling told me, haven’t just made flight a breeze for bats. They also mitigate other types of bodily harm. Cancer tends to unfurl after errors appear in particular parts of our genetic code. And, molecularly speaking, aging is basically what happens to the body as it accumulates a lifetime of cellular wear and tear. In a sense, stress is simply stress: The root causes of these chronic health issues overlap with the greatest taxes of flight. So the solutions that keep a bat body running smoothly in the air can address problems throughout its lifetime. While humans get worse at repairing damage with age, bats’ ability improves, Teeling told me.

    All of this can also help explain why bats are such hospitable hosts for pathogens that can kill us. Many of the most dangerous cases of infectious disease are driven by the body’s overzealous inflammatory response; that reaction can pose a greater threat than any damage that a pathogen itself might do to cells. Many of our defenses are like bombs set off on our home turf—capable of killing invaders, yes, but at great cost to us. Bats have such a high threshold for igniting inflammation that many viruses seem able to inhabit their tissues without setting off that degree of destruction. In laboratory experiments, bats have been dosed with so much virus that their tissues end up chock-full—clocking some 10 million units of Ebola virus per milliliter of serum, or 10 million units of the MERS coronavirus per gram of lung——and researchers were still unable to discern serious problems with the bats’ health. Bats and their viruses have, in effect, struck “an immunological detente,” says Tony Schountz, a bat immunologist at Colorado State University.

    Such astronomical levels of virus aren’t a bat’s preferred state. Bat bodies also happen to be very good at tamping down viral replication up front. Part of the reason seems to be that, in certain bat species’ bodies, parts of their antiviral defense system “are always on,” Wang told me. “I call them ‘battle ready.’” So when a pathogen does appear, it knocks up against a host that is already teeming with powerful proteins, ready-made to block parts of the viral life cycle, hindering the microbe from spinning out of control.

    The catch here is that the viruses have wised up to bats’ tricks—and evolved to be more forceful as they attempt to infiltrate and replicate inside of, and then spread between, those well-defended cells. And that bat-caliber offense can be excessive in a human that lacks the same shields, says Cara Brook, a disease ecologist at the University of Chicago. That might help explain why so many bat viruses hit us so hard.. Couple that show of force with our difficulties reining in our own inflammation, and what might have been a trivial infection for a bat can turn into utter chaos for a person.

    One of Wang’s primary ideas for dealing with this kind of host-pathogen mismatch is to use drugs to make our inflammatory responses a bit more muted—that is, a bit more bat-like. That option is especially intriguing, he told me, because it could also lower the risk of autoimmunity, maybe even forestall aging or certain kinds of chronic metabolic disease. His bat-mouse, which was engineered to express a particular inflammation-suppressing bat gene, is an experiment with that principle, and it seemed to fare better against flu, SARS-CoV-2, even gout crystals.

    But the idea of muffling inflammation isn’t exactly new: Our medical armamentarium has included steroids and other immune-system-modulating drugs for decades. All have their limits and their drawbacks, and a treatment specifically inspired by bats would likely be subject to the same caveats, says Arinjay Banerjee, a virologist and bat immunologist at the University of Saskatchewan. Inflammation, as damaging as it can be, is an essential defense. Any drug that modifies it—especially one taken long-term—must avoid the hurt of too much while skirting the risk of not enough. And ultimately, humans just aren’t bats. Plop a bat’s defense into a human body, and it might not work in the way researchers expect, says Hannah Frank, a bat immunologist at Tulane University. To truly see bat-like benefits in people, chances are, we’d need more than one treatment turning more than one physiological dial, Banerjee told me.

    As much as researchers are learning about bats, the gaps in their knowledge are still huge. What’s observed in one of the more than 1,400 species of bats may not hold true for another. Plus, bat physiology is distinct enough from ours that no one really can precisely say what optimal health for them looks like, Frank told me. Although bats rarely die from their viruses, those infections may be still taking a toll in ways that researchers have yet to appreciate, Brook told me. Bats aren’t the only intriguing virus-carriers, either. Rodents, too, haul around a lot of deadly pathogens without falling sick, as Schountz points out. Nor are they the only mammals that live at extremes. Naked mole rats withstand low-oxygen conditions underground; seals must cope with organ-crushing pressures when they dive. Like flight, those adaptations may have rejiggered immunity in yet untold ways.

    Certainly, though, bats have more to offer us than many people give them credit for. In the aftermath of a Hendra virus outbreak in Australia, years ago, “we even had a politician say, Let’s bomb the bats,” Wang told me. The start of the coronavirus pandemic, too, ignited calls for bat cullings; some animals were even reportedly burned out of roosts. “I still don’t want a bat as a pet,” Wang told me. But if his findings keep panning out, maybe someday people will associate bats less with the diseases we don’t want to get from them, and more with the healthy traits we do.

    [ad_2]

    Katherine J. Wu

    Source link

  • GOP measures would undo protections for endangered lesser prairie chicken, northern bat

    GOP measures would undo protections for endangered lesser prairie chicken, northern bat

    [ad_1]

    WASHINGTON — Congress has approved two measures to undo federal protections for the lesser prairie chicken and northern long-eared bat — two endangered animals that have seen their populations plummet over the years.

    In separate votes Thursday, the House gave final legislative approval to rescind protections for the lesser prairie chicken — a rare prairie bird once thought to number in the millions, but now hover around 30,000, officials said — and the long-eared bat, one of 12 bat types decimated by a fungal disease called white-nose syndrome.

    The legislative actions, backed mostly by Republicans, represent rare congressional involvement in matters usually left to the U.S. Fish and Wildlife Service and the National Marine Fisheries Service. The Endangered Species Act tasks the agencies with deciding which animals and plants to list as endangered or threatened and how to rebuild their populations.

    The lesser prairie chicken, which belongs to the grouse family, is found in parts of the Midwest and Southwest, including one of the country’s most prolific oil and gas fields — the oil-rich Permian Basin in New Mexico and Texas. The bird’s range also extends into parts of Colorado, Oklahoma and Kansas, but has diminished across about 90% of its historical range, officials said.

    The House voted 221-206 to reverse protections for the prairie bird.

    A separate 220-209 vote would overturn protections for the northern long-eared bat, which has seen its population reduced by 97% or more in some areas because of white-nose syndrome. The bat is found in 37 eastern and north-central states, plus Washington, D.C., and much of Canada.

    The House votes follow similar action in the Senate in May and send both plans to President Joe Biden, who has threatened to veto both resolutions.

    Overturning protections for the lesser prairie chicken “would undermine America’s proud wildlife conservation traditions, risk the extinction of a once-abundant American bird and create uncertainty for landowners and industries who have been working for years to forge the durable, locally led conservation strategies that this rule supports,” the White House said in a statement.

    In a separate statement, the White House said bats are “critical to healthy, functioning ecosystems and contribute at least $3 billion annually to the U.S. agriculture economy through pest control and pollination.” Overturning protections “would risk extinction of a species.”

    Environmentalists have long sought stronger federal protections for the prairie bird, which they consider severely at risk due to oil and gas development, livestock grazing and farming, along with roads and power lines.

    The crow-size, terrestrial birds are known for spring courtship rituals that include flamboyant dances by the males as they make a cacophony of clucking, cackling and booming sounds.

    White-nose syndrome, meanwhile, has spread across about 80% of the northern bat’s range and caused a precipitous decline in bat populations. Critics of the endangered listing contend it would hamper logging and other land uses that aren’t responsible for the bat’s sharp decline.

    Rep. Bruce Westerman, an Arkansas Republican who chairs the House Natural Resources Committee, called the Endangered Species Act an important but outdated part of U.S. history.

    “The unavoidable truth about the ESA is that a listing means less private investment, which harms conservation efforts,” he said.

    In the case of the lesser prairie chicken, the protected status “is a tool for Fish and Wildlife to go implement the Biden administration’s none-of-the- above energy policy,” Westerman said on the House floor. “It’s another attack on low-cost energy for the American taxpayers. It’s an attack on jobs in America and it’s making us more dependent” on hostile countries in the Middle East and South America, he said.

    Arizona Rep. Raul Grijalva, the top Democrat on the natural resources panel, said the GOP measures “give industry and not science the upper hand in making decisions about endangered species.”

    He labeled Republican opposition to the Endangered Species Act “a vendetta.” He also said the two votes on Thursday were egregious since the GOP-controlled House has not taken action to address climate change, even as Arizona and other states suffer through “one of the most brutal summers in this country’s recorded history.”

    Climate change “isn’t about some distant warning about melting icecaps in the far-off future. The climate crisis is here, it is now,” Grijalva said, noting that Phoenix has set a record with a 27-day streak of temperatures over 110 degree Fahrenheit.

    “People are suffering. People are dying, and the GOP isn’t doing a thing about it,” he said.

    The Republican majority “has had zero hearings on climate change” since taking over in January and has ”introduced zero bills to seriously address climate change,” Grijalva said.

    The House votes follow actions by Congress earlier this year to block a clean water rule imposed by the Environmental Protection Agency and a separate Labor Department measure that allows retirement plan managers to consider the effects of climate change in their investment plans. Biden vetoed both legislative measures.

    [ad_2]

    Source link

  • WHO fires scientist who led COVID search over sex misconduct

    WHO fires scientist who led COVID search over sex misconduct

    [ad_1]

    GENEVA — The World Health Organization says it has fired the scientist who led a high-profile delegation from the U.N. health agency to China two years ago to jointly look into the origins of the coronavirus pandemic, citing sexual misconduct.

    Peter Ben Embarek, who led the WHO side of a joint team with scientists in China, was dismissed last year, the health agency said. WHO says it has stepped up efforts to root out sexual abuse, exploitation and harassment in recent months after a string of cases and incidents were reported in the press.

    “Peter Ben Embarek was dismissed following findings of sexual misconduct against him and corresponding disciplinary process,” said spokeswoman Marcia Poole said in an email. “The findings concern allegations relating to 2015 and 2017 that were first received by the WHO investigations team in 2018.”

    She said other allegations could not be fully investigated as the “victim(s) did not wish to engage with the investigation process.”

    Ben Embarek did not immediately respond to a call or text message to his mobile phone on Thursday. The news was first reported by The Financial Times.

    Ben Embarek led an international team picked by WHO that traveled to China in early 2021, visited the Huanan market in Wuhan — the city where the first human cases appeared — and worked closely with Chinese scientists to try to identify how the virus first began sickening people.

    The team issued a report in March that year that said the most likely scenario was that COVID-19 jumped from bats to humans via another animal, dismissing a lab leak as “extremely unlikely.” WHO officials, including Director-General Tedros Adhanom Ghebreyesus, have since said that the origins remain unclear and the lab-leak theory cannot be ruled out.

    Ben Embarek, a Danish expert on disease transmission from animals to humans, told a TV program in Denmark later in 2021 that he had concerns about a Chinese lab near the market later in 2021.

    The impact of Ben Embarek’s dismissal on efforts to solve that lingering enigma remains unclear. The joint WHO-China team has since been disbanded, and a separate panel of experts drafted by WHO has taken up the role of trying to find the origins of the coronavirus.

    Word of the dismissal comes as WHO is convening an expert group this week to decide if COVID-19 remains an international health emergency, after sharp declines in case counts and deaths from the pandemic in recent months — even if pockets of cases continue.

    WHO says it has been working to root out sexual abuse, exploitation and harassment in its ranks after press reports first arose in 2020 about systemic abuse of dozens of women during the agency’s response to an Ebola outbreak in Congo.

    More than 80 staffers under the direction of WHO and partners were alleged to have raped women and young girls, demanded sex in return for jobs and forced some victims to have abortions, in the biggest known sex abuse scandal in the U.N. health agency’s history.

    Not a single senior manager connected to the Congo abuse has been dismissed, despite documents showing WHO leaders were aware as it was happening. An internal U.N. report submitted to WHO earlier this year found that despite senior managers being informed of the sexual abuse, no misconduct was committed.

    Last month, WHO said it fired Fijian doctor Temo Waqanivalu, who faced allegations first reported by the AP, that he had repeatedly engaged in sexual harassment.

    [ad_2]

    Source link